iBio, Inc. — Director's Dealing 2017

Feb 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2017-02-23

Reporting Person: DART KENNETH BRYAN (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-23	Preferred Stock	P	1	—	Acquired	1	Indirect

Footnotes

F1: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.